Haitao Zhu Selected Research

Vimentin

7/2017	Solamargine inhibits the migration and invasion of HepG2 cells by blocking epithelial-to-mesenchymal transition.
9/2014	Upregulation of autophagy by hypoxia-inducible factor-1α promotes EMT and metastatic ability of CD133+ pancreatic cancer stem-like cells during intermittent hypoxia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Haitao Zhu Research Topics

Disease

45	Neoplasms (Cancer) 06/2022 - 04/2009
16	Neoplasm Metastasis (Metastasis) 04/2022 - 01/2010
11	Pancreatic Neoplasms (Pancreatic Cancer) 06/2022 - 05/2013
10	Inflammation (Inflammations) 10/2022 - 05/2015
8	Necrotizing Enterocolitis 01/2022 - 10/2019
8	Parkinson Disease (Parkinson's Disease) 01/2019 - 04/2010
6	Hypoxia (Hypoxemia) 01/2022 - 09/2014
5	Fibrosis (Cirrhosis) 09/2018 - 10/2012
5	Stomach Neoplasms (Stomach Cancer) 01/2018 - 01/2013
5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2018 - 01/2013
5	Neuroblastoma 12/2013 - 04/2009
4	Colorectal Neoplasms (Colorectal Cancer) 03/2022 - 10/2019
4	Diabetes Mellitus 01/2021 - 01/2014
4	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 07/2012
3	Atherosclerosis 10/2022 - 12/2015
3	Lymphatic Metastasis 01/2022 - 06/2015
3	Compression Fractures (Compression Fracture) 08/2021 - 01/2019
3	Wounds and Injuries (Trauma) 01/2021 - 12/2019
3	Myocardial Infarction 01/2021 - 12/2019
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2019 - 06/2015
3	Adenocarcinoma 09/2019 - 05/2013
3	Myocarditis (Carditis) 09/2014 - 12/2011
2	Pain (Aches) 06/2022 - 09/2017
2	Necrosis 01/2021 - 01/2019
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 12/2015
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 05/2017
2	Insulin Resistance 01/2021 - 01/2021
2	Seizures (Absence Seizure) 09/2020 - 04/2020
2	Disease Progression 12/2019 - 01/2016
2	Esophageal Squamous Cell Carcinoma 12/2019 - 01/2019
2	Carcinogenesis 10/2019 - 01/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 09/2018 - 12/2011
2	Gliosis 01/2017 - 05/2015
2	Neuroinflammatory Diseases 01/2017 - 01/2016
2	Brain Edema (Cerebral Edema) 01/2017 - 01/2016
2	Thrombosis (Thrombus) 12/2015 - 05/2009

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2009
9	Phosphotransferases (Kinase)IBA 01/2021 - 04/2010
8	HMGB1 Protein (HMG1)IBA 02/2019 - 12/2011
7	Leucine (L-Leucine)FDA Link 01/2021 - 04/2010
5	EnzymesIBA 06/2022 - 05/2015
5	CateninsIBA 10/2019 - 06/2015
4	Long Noncoding RNAIBA 01/2020 - 01/2019
4	Small Interfering RNA (siRNA)IBA 05/2017 - 01/2013
4	CurcuminIBA 01/2017 - 05/2015
3	Advanced Glycation End ProductsIBA 07/2022 - 01/2021
3	IronIBA 01/2022 - 05/2016
3	Biological ProductsIBA 04/2021 - 01/2014
3	LipopolysaccharidesIBA 03/2021 - 02/2020
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 05/2015
3	Proliferating Cell Nuclear Antigen (PCNA)IBA 12/2019 - 04/2009
3	Cadherins (E-Cadherin)IBA 07/2017 - 09/2014
3	Endocrine DisruptorsIBA 05/2013 - 04/2009
3	bisphenol AIBA 05/2013 - 04/2009
2	LipidsIBA 10/2022 - 01/2021
2	Gemcitabine FDA Link 06/2022 - 03/2018
2	Mitochondrial DNA (mtDNA)IBA 04/2022 - 03/2022
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2021
2	OligosaccharidesIBA 01/2022 - 11/2020
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2021
2	Protein Kinases (Protein Kinase)IBA 01/2021 - 12/2014
2	GoldIBA 01/2021 - 01/2020
2	Therapeutic UsesIBA 01/2021 - 09/2018
2	CalciumIBA 01/2021 - 12/2014
2	Pharmaceutical PreparationsIBA 09/2020 - 06/2015
2	NestinIBA 04/2020 - 05/2013
2	S100 Proteins (S 100 Protein)IBA 04/2020 - 05/2017
2	Glial Fibrillary Acidic ProteinIBA 04/2020 - 05/2015
2	LactoferrinIBA 02/2020 - 12/2019
2	Surface-Active Agents (Surfactants)IBA 01/2020 - 08/2019
2	CytokinesIBA 12/2019 - 05/2015
2	MicroRNAs (MicroRNA)IBA 10/2019 - 01/2018
2	Toll-Like Receptor 2IBA 02/2019 - 01/2019
2	Interleukin-23 (Interleukin 23)IBA 01/2019 - 06/2015
2	VimentinIBA 07/2017 - 09/2014
2	ErbB Receptors (EGF Receptor)IBA 05/2017 - 10/2015
2	Monoclonal AntibodiesIBA 03/2017 - 12/2011
2	ChemokinesIBA 01/2017 - 01/2016
2	CC ChemokinesIBA 01/2016 - 01/2015
2	LigandsIBA 01/2016 - 01/2015
2	Transforming Growth Factors (Transforming Growth Factor)IBA 05/2015 - 01/2015
2	Messenger RNA (mRNA)IBA 01/2014 - 01/2013
2	Interleukin-17 (Interleukin 17)IBA 01/2014 - 10/2012
2	Diethylhexyl Phthalate (DEHP)IBA 05/2013 - 01/2010
2	phthalic acid (phthalate)IBA 05/2013 - 01/2010
1	Losartan (Cozaar)FDA LinkGeneric 10/2022
1	Transcription Factors (Transcription Factor)IBA 06/2022
1	Deoxycytidine KinaseIBA 06/2022

Therapy/Procedure

19	Therapeutics 10/2022 - 07/2012
12	Drug Therapy (Chemotherapy) 06/2022 - 07/2012
7	Radiotherapy 01/2021 - 01/2014
3	Transplantation 06/2022 - 01/2018
3	Immunotherapy 11/2021 - 03/2017
3	Kyphoplasty 08/2021 - 01/2019
3	Length of Stay 03/2021 - 09/2017
2	Precision Medicine 01/2021 - 01/2021
2	Aftercare (After-Treatment) 09/2020 - 06/2015
2	Photothermal Therapy 01/2020 - 01/2020
2	Heterologous Transplantation (Xenotransplantation) 03/2018 - 01/2013
2	Islets of Langerhans Transplantation 10/2015 - 01/2014